BARCLAYS PLC - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 164 filers reported holding ASCENDIS PHARMA A/S in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q3 2023$1,637
+2931.5%
17,482
+2775.3%
0.00%
Q2 2023$54
-99.3%
608
-99.1%
0.00%
-100.0%
Q1 2023$7,388
+6.7%
68,902
+21.5%
0.00%0.0%
Q4 2022$6,926
-99.9%
56,707
-54.6%
0.00%
-78.6%
Q3 2022$12,889,000
-4.4%
124,821
-13.9%
0.01%
+75.0%
Q2 2022$13,483,000
+13118.6%
145,044
+16668.1%
0.01%
Q1 2022$102,000
-39.3%
865
-31.0%
0.00%
Q4 2021$168,000
-98.6%
1,254
-98.3%
0.00%
-100.0%
Q3 2021$11,637,000
+12830.0%
73,009
+10558.2%
0.01%
Q2 2021$90,000
-82.7%
685
-83.0%
0.00%
Q1 2021$520,000
-28.1%
4,039
-6.9%
0.00%
Q4 2020$723,000
+13.7%
4,337
+5.2%
0.00%
Q3 2020$636,000
+8.0%
4,121
+3.5%
0.00%
Q2 2020$589,000
+1491.9%
3,983
+1110.6%
0.00%
Q1 2020$37,000
-28.8%
329
-13.0%
0.00%
Q4 2019$52,000
-93.7%
378
-95.6%
0.00%
-100.0%
Q3 2019$829,000
+2338.2%
8,611
+2789.6%
0.00%
Q2 2019$34,000
-99.9%
298
-99.9%
0.00%
-100.0%
Q1 2019$24,259,000
+559.2%
206,111
+250.9%
0.02%
+466.7%
Q4 2018$3,680,000
+933.7%
58,733
+1070.0%
0.00%
Q3 2018$356,000
+9.5%
5,020
+2.8%
0.00%
Q2 2018$325,000
-5.8%
4,883
-7.2%
0.00%
Q1 2018$345,000
+83.5%
5,260
+11.9%
0.00%
Q4 2017$188,000
+3.9%
4,700
-6.0%
0.00%
Q3 2017$181,0005,0000.00%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q3 2023
NameSharesValueWeighting ↓
RA Capital Management 5,865,338$978,221,00013.68%
Vivo Capital, LLC 1,797,745$299,828,00013.38%
Sofinnova Investments, Inc. 1,109,874$185,105,00011.02%
Avoro Capital Advisors LLC 1,800,000$300,204,0005.17%
Eventide Asset Management 1,704,148$284,218,0004.36%
Stenahm Asset Managment Ltd 29,000$4,837,0004.07%
Ghost Tree Capital, LLC 105,000$17,512,0003.90%
Eversept Partners, LP 187,043$31,195,0323.66%
Spyglass Capital Management LLC 701,594$117,012,0003.59%
Q Global Advisors, LLC 23,183$3,866,0002.72%
View complete list of ASCENDIS PHARMA A/S shareholders